Product

Prednisone + Ustekinumab

Aliases

prednisone and ustekinumab treatment

2 clinical trials

2 indications

Indication

Patients With Newly Diagnosed Active NISU

Indication

Giant Cell Arteritis

Clinical trial

A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)

Status: Terminated, Estimated PCD: 2023-10-25

Clinical trial

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis

Status: Recruiting, Estimated PCD: 2025-01-01